Is there a role for antidepressants in the treatment of bipolar II depression?

American Journal of Psychiatry

Volumn 167, Issue 7, 2010, Pages 738-740

  Suppes, Trisha ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; LITHIUM; PLACEBO;

BIPOLAR DEPRESSION; BIPOLAR II DISORDER; CLINICAL PRACTICE; CLINICAL TRIAL; EDITORIAL; HUMAN; HYPOMANIA; MENTAL PATIENT; MONOTHERAPY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECURRENT DISEASE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIPOLAR DISORDER; FLUOXETINE; HUMANS; LITHIUM COMPOUNDS; TREATMENT OUTCOME;

EID: 77954224022     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2010.10040590     Document Type: Editorial

References (10)

1. Amsterdam JD, Shults J: Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am J Psychiatry 2010; 167:792-800
2. Vieta E, Suppes T: Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disorders 2008; 10(1 Pt 2):163-178
3. Ghaemi SN, Klara JR, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ: Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry 2004; 161:163-165 (Pubitemid 38419324)
4. Altshuler L, Suppes T, Black D, Nolen WA, Keck P, Frye MA, McElroy S, Kupka R, Grunze H, Walden J, Leverich G, Denicoff K: Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003; 160:1252-1262 (Pubitemid 41070941)
5. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, Friedman ES, Bowden CL, Fossey MD, Ostacher MJ, Ketter TA, Patel J, Hauser P, Rapport D, Martinez JM, Allen MH, Miklowitz DJ, Otto MW, Dennehy EB, Thase ME: Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007; 356:1711-1722
6. McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C , Nordenhem A, Young AH; EMBOLDEN II (Trial D1447C00134) Investigators: A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 2010; 71:163-174
7. Suppes T, Mintz J, McElroy SL, Altshuler LL, Kupka RW, Frye MA, Keck PE, Nolen WA, Leverich GS, Grunze H, Rush J, Post RM: Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Treatment Network. Arch Gen Psychiatry 2005: 62:1089-1096.
8. Goldberg JF, Perlis RH, Bowden CL, Thase ME, Miklowitz DJ, Marangell LB, Calabrese JR, Nierenberg AA, Sachs GS: Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD. Am J Psychiatry 2009; 166: 173-181
9. Frye MA, Helleman G, McElroy SL, Altshuler LL, Black DO, Keck PE Jr, Nolen WA, Kupka R, Leverich GS, Grunze H, Mintz J, Post RM, Suppes T: Correlates of treatment-emergent mania associated with antidepressant treatment in bipolar depression. Am J Psychiatry 2009; 166:164-172
10. Dilsaver SC , Benazzi F, Akiskal HS: Mixed states: the most common outpatient presentation of bipolar depressed adolescents? Psychopathology 2005; 38:268-272